Clinical Trial Update: A Combination of Avelumab and Taxane (AVETAX) for Urothelial Cancer [Phase 1]

View source ↗

Summary

This clinical trial update reports on a Phase 1 study evaluating the combination of avelumab with a taxane for urothelial carcinoma, which has completed the Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Avelumab (avelumab)
• Taxane (paclitaxel or docetaxel)

Snippet

Sponsor: Yousef Zakharia | Conditions: Urothelial Carcinoma | Phase 1 | Status: COMPLETED